| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/19/2009 | EP2089420A2 Proteins for use in diagnosing and treating infection and disease |
| 08/19/2009 | EP2089388A2 Process for the synthesis of moxifloxacin hydrochloride |
| 08/19/2009 | EP2089384A2 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/19/2009 | EP2089383A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 08/19/2009 | EP2089025A1 Thuggacin-type macrolide antibiotics and their use as antimycobacterial agents |
| 08/19/2009 | EP2089020A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/19/2009 | EP2088860A1 Chemokine receptor binding compounds |
| 08/19/2009 | EP1871395A4 Garlic extract and chitosan compositions, and uses thereof |
| 08/19/2009 | EP1685123B1 Substituted dihydroquinazolines ii |
| 08/19/2009 | EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1480653B1 Ribavirin syrup formulations |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1351677A4 Method for treating cancer |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses |
| 08/19/2009 | EP0942987B1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 08/19/2009 | CN101511845A Spiro antibiotic derivatives |
| 08/19/2009 | CN101511826A Preparation and purification of mupirocin calcium |
| 08/19/2009 | CN101511806A New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment |
| 08/19/2009 | CN101511431A Treating mycobacterial infections with Cyclipostins |
| 08/19/2009 | CN101511430A Antibiotic composition |
| 08/19/2009 | CN101511374A Use of tylvalosin as antiviral agent |
| 08/19/2009 | CN101511360A Compositions and method for the treatment of mucormycosis and other epiphyte diseases |
| 08/19/2009 | CN101511358A Freeze-dried preparation of 1-methylcarbapenem |
| 08/19/2009 | CN101509009A Amalgamation gene of hepatitis B virus L gene and Ag85B, construction and uses of its expression vector |
| 08/19/2009 | CN101509008A Amalgamation gene of hepatitis B virus L gene and hGM-CSF, construction and uses of its expression vector |
| 08/19/2009 | CN101509003A Sequence of enterovirns type71 genome and uses thereof |
| 08/19/2009 | CN101508993A Bullfrog lectin gene, encoded lectin and uses thereof |
| 08/19/2009 | CN101508978A Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof |
| 08/19/2009 | CN101508977A Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof |
| 08/19/2009 | CN101508733A Human avian influenza specific immunity globulin and preparation thereof |
| 08/19/2009 | CN101508717A Synthesis of tuberculosis resistant compound of arguesterol |
| 08/19/2009 | CN101508695A Indolizine-peptide piperazine diketone derivatives, preparation and antimicrobial uses thereof |
| 08/19/2009 | CN101508671A Aza saccharide compounds, synthesis and uses thereof |
| 08/19/2009 | CN101507816A Riemerlla anatipestifer bivalent inactivated vaccine and preparation method thereof |
| 08/19/2009 | CN101507815A Vibrio harveyi recombined outer-membrane protein Ompk microspheres vaccine and preparation method thereof |
| 08/19/2009 | CN101507814A Multi-component antigen acellular pertussis vaccine and preparation method thereof |
| 08/19/2009 | CN101507813A Technique for removing meningococcus polysaccharide endotoxin |
| 08/19/2009 | CN101507812A Aluminum adjuvant dry-power vaccine and preparation method thereof |
| 08/19/2009 | CN101507808A Medicine for treating hepatitis B and manufacture method thereof |
| 08/19/2009 | CN101507803A Health-protection medicine granule |
| 08/19/2009 | CN101507799A Miao medicine 103 deer-blood element medicine for resisting multi-drug resistant pulmonary tuberculosis and preparation method of 103 deer-blood element |
| 08/19/2009 | CN101507791A Antiviral medicine and preparation method thereof |
| 08/19/2009 | CN101507779A Chinese patent medicine for treating urgent, chronic viral hepatitis type B |
| 08/19/2009 | CN101507778A Tea-leaf extract with anti-HIV activity and application method thereof |
| 08/19/2009 | CN101507762A Veterinary medicine for treating colibacillosis and white dysentery |
| 08/19/2009 | CN101507755A Preparation method of high-purity magnolia bark total-phenol |
| 08/19/2009 | CN101507754A Traditional Chinese medicine preparation for treating coryza and preparation method thereof |
| 08/19/2009 | CN101507748A External medicine liquor for treating common cold and preparation method thereof |
| 08/19/2009 | CN101507743A Biennial wormwood extract and preparation method thereof |
| 08/19/2009 | CN101507725A Use of stephanine and hydrochloride thereof in preparing anti-hepatitis virus medicine |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100529058C Novel microorganism and its gene fragment order and application |
| 08/19/2009 | CN100529054C Modulating production of pneumococcal capsular polysaccharide |
| 08/19/2009 | CN100528866C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 08/19/2009 | CN100528846C Amine compounds and use thereof |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528238C Oral DNA combination for treating chronic infection of hepatitis B virus |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528234C Lactobionic acid azithromycin for injections and preparation method thereof |
| 08/19/2009 | CN100528228C Escape mutants of newcastle disease virus as marker vaccines |
| 08/19/2009 | CN100528227C Vaccine for virus of encephalitis B and preparation method |
| 08/19/2009 | CN100528226C Virus-like particles of human papillomavirus |
| 08/19/2009 | CN100528221C Anti-hepatitis B virus medicine agent and its preparing process |
| 08/19/2009 | CN100528218C Pharmaceutical composition, its preparation process and usage |
| 08/19/2009 | CN100528209C Preparation method of traditional Chinese medicine preparation having functions of invigorating qi and yin and blood and releasing poison |
| 08/19/2009 | CN100528207C Medicine for treating pulmonary tuberculosis and its preparing process |
| 08/19/2009 | CN100528173C 4'-substituted nucleosides |
| 08/19/2009 | CN100528172C Oral medicine for treating turtle parotiditis |
| 08/19/2009 | CN100528171C Oil-in-water baicalin nano-milk oral liquid and its preparing process |
| 08/19/2009 | CN100528160C An antibacterial rifampicin nanoemulsion and preparation method thereof |
| 08/19/2009 | CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576234 Synthesis of 2-alkyl amino acids |
| 08/18/2009 | US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS |
| 08/18/2009 | US7576194 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection; for immunodiagnosis and immunoprophylaxis |
| 08/18/2009 | US7576176 Neisseria meningitidis antigens and compositions |
| 08/18/2009 | US7576117 Cyclic amine CCR3 antagonist |
| 08/18/2009 | US7576097 Crystalline form of maraviroc |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576070 for inhibiting galectin-3- mediated cell-cell and/or cell-matrix Interactions leading to tumor diseases; hydrolyzing enzyme A |
| 08/18/2009 | US7576068 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus |
| 08/18/2009 | US7575918 GENETIC ENGINEERED nucleic acid, VECTOR CODING ANTISENSE AGENTS; FOR USE IN KILLING PREFERENTIAL TARGET CELLS OR MICRORGANISMS; biodrugs as antitumor agent, bactericides, anticarcinogenic agent; target on antibiotic resistant bacteria, drug-resistant cancer cells |
| 08/18/2009 | US7575894 Human recombinant beta-interferon with improved solubility |
| 08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 08/18/2009 | CA2495721C Non-nucleoside reverse transcriptase inhibitors |
| 08/18/2009 | CA2479216C Dipyridodiazepinones as reverse transcriptase inhibitors |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2401569C Low dose entecavir formulation and use |
| 08/18/2009 | CA2362760C Camptothecin derivatives having antitumor activity |
| 08/18/2009 | CA2335250C Temperature-sensitive liposomal formulation |
| 08/18/2009 | CA2288215C Use of immunomodulating agents |
| 08/18/2009 | CA2224008C The treatment of hiv and other viral infections using combinatorial therapy |
| 08/13/2009 | WO2009100456A2 Inhibition and treatment of gastrointestinal biofilms |
| 08/13/2009 | WO2009100323A2 Methods of using carboxylic amides as antimicrobial agents |
| 08/13/2009 | WO2009100194A2 Camptothecin-binding moiety conjugates |
| 08/13/2009 | WO2009099777A2 Chimeric hiv fusion proteins as vaccines |
| 08/13/2009 | WO2009099596A2 Macrocyclic serine protease inhibitors |